Humana Inc. (NYSE: HUM) Stock Competitors & Peer Comparison
See HUM's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HUM and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HUM | $405.90 | -2.59% | 49.8B | 26.15 | $15.86 | +0.86% |
| UNH | $398.59 | -3.00% | 365.2B | 21.83 | $18.64 | +2.22% |
| CVS | $88.17 | -2.39% | 115.4B | 11.51 | $7.84 | +2.95% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $410.10 | -2.82% | 91.1B | 14.29 | $29.39 | +1.64% |
| CI | $293.31 | -1.71% | 78.8B | 9.65 | $30.90 | +2.08% |
| CNC | $65.30 | -4.84% | 33.9B | 27.16 | $2.52 | N/A |
| MOH | $201.07 | +1.07% | 10.8B | 29.77 | $6.92 | N/A |
| OSCR | $30.05 | -2.40% | 7.9B | 21.69 | $1.40 | N/A |
| CLOV | $4.35 | -5.03% | 2.4B | 104.83 | $0.04 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
HUM vs UNH Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, UNH has a market cap of 365.2B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while UNH trades at $398.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas UNH's P/E ratio is 21.83. In terms of profitability, HUM's ROE is +0.07%, compared to UNH's ROE of +0.16%. Regarding short-term risk, HUM is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for HUM.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
HUM vs CVS Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, CVS has a market cap of 115.4B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while CVS trades at $88.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas CVS's P/E ratio is 11.51. In terms of profitability, HUM's ROE is +0.07%, compared to CVS's ROE of +0.06%. Regarding short-term risk, HUM is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for HUM.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
HUM vs ANTM Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas ANTM's P/E ratio is 18.99. In terms of profitability, HUM's ROE is +0.07%, compared to ANTM's ROE of +0.12%. Regarding short-term risk, HUM is more volatile compared to ANTM. This indicates higher risk in terms of short-term price fluctuations for HUM.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
HUM vs ELV Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, ELV has a market cap of 91.1B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while ELV trades at $410.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas ELV's P/E ratio is 14.29. In terms of profitability, HUM's ROE is +0.07%, compared to ELV's ROE of +0.12%. Regarding short-term risk, HUM is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for HUM.Check ELV's competition here
Cigna Corporation (NYSE: CI)
HUM vs CI Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, CI has a market cap of 78.8B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while CI trades at $293.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas CI's P/E ratio is 9.65. In terms of profitability, HUM's ROE is +0.07%, compared to CI's ROE of +0.15%. Regarding short-term risk, HUM is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for HUM.Check CI's competition here
Centene Corp. (NYSE: CNC)
HUM vs CNC Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, CNC has a market cap of 33.9B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while CNC trades at $65.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas CNC's P/E ratio is 27.16. In terms of profitability, HUM's ROE is +0.07%, compared to CNC's ROE of +0.07%. Regarding short-term risk, HUM is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for HUM.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
HUM vs MOH Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, MOH has a market cap of 10.8B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while MOH trades at $201.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas MOH's P/E ratio is 29.77. In terms of profitability, HUM's ROE is +0.07%, compared to MOH's ROE of -0.01%. Regarding short-term risk, HUM is more volatile compared to MOH. This indicates higher risk in terms of short-term price fluctuations for HUM.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
HUM vs OSCR Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, OSCR has a market cap of 7.9B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while OSCR trades at $30.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas OSCR's P/E ratio is 21.69. In terms of profitability, HUM's ROE is +0.07%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, HUM is more volatile compared to OSCR. This indicates higher risk in terms of short-term price fluctuations for HUM.Check OSCR's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
HUM vs CLOV Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, CLOV has a market cap of 2.4B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while CLOV trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas CLOV's P/E ratio is 104.83. In terms of profitability, HUM's ROE is +0.07%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, HUM is more volatile compared to CLOV. This indicates higher risk in terms of short-term price fluctuations for HUM.Check CLOV's competition here
Progyny, Inc. (NASDAQ: PGNY)
HUM vs PGNY Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, PGNY has a market cap of 2.2B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while PGNY trades at $29.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas PGNY's P/E ratio is 30.11. In terms of profitability, HUM's ROE is +0.07%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, HUM is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for HUM.Check PGNY's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
HUM vs ALHC Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, ALHC has a market cap of 1.5B. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while ALHC trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas ALHC's P/E ratio is 38.34. In terms of profitability, HUM's ROE is +0.07%, compared to ALHC's ROE of +0.12%. Regarding short-term risk, HUM is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for HUM.Check ALHC's competition here
Bright Health Group, Inc. (NYSE: BHG)
HUM vs BHG Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas BHG's P/E ratio is -0.12. In terms of profitability, HUM's ROE is +0.07%, compared to BHG's ROE of +0.59%. Regarding short-term risk, HUM is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for HUM.Check BHG's competition here
Universal American Corporation (NYSE: UAM)
HUM vs UAM Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, UAM has a market cap of 0. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas UAM's P/E ratio is 1.01. In terms of profitability, HUM's ROE is +0.07%, compared to UAM's ROE of +0.17%. Regarding short-term risk, HUM is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for HUM.Check UAM's competition here
Aetna Inc. (NYSE: AET)
HUM vs AET Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, AET has a market cap of 0. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas AET's P/E ratio is 9.57. In terms of profitability, HUM's ROE is +0.07%, compared to AET's ROE of +0.11%. Regarding short-term risk, HUM is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for HUM.Check AET's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
HUM vs MGLN Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas MGLN's P/E ratio is 8.49. In terms of profitability, HUM's ROE is +0.07%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, HUM is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for HUM.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
HUM vs GTS Comparison November 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 49.8B. In comparison, GTS has a market cap of 0. Regarding current trading prices, HUM is priced at $405.90 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 26.15, whereas GTS's P/E ratio is 10.41. In terms of profitability, HUM's ROE is +0.07%, compared to GTS's ROE of +0.07%. Regarding short-term risk, HUM is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for HUM.Check GTS's competition here